Sort
82,697 grants matching “vaccine development”
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,191,623D Gary Gilliland · Dana-Farber Cancer Inst · P01 · FY2006 · CA
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
$2,191,356Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
Non-Human Primate Discovery Team
$2,190,977Norman L Letvin · Duke University · U19 · FY2011 · AI
Center for Experimental Infectious Disease Research
$2,190,854Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2013 · GM
Obesity-driven alterations in humoral B cell immunity
$2,190,435Elizabeth Ann Leadbetter · University Of Texas Hlth Science Center · R01 · FY2025 · AI
SPORE in Prostate Cancer
$2,190,123Samuel R Denmeade · Johns Hopkins University · P50 · FY2024 · CA
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$2,190,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2018 · IP
Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases
$2,189,410William W. Kwok · Benaroya Research Inst At Virginia Mason · N01 · FY2011 · AI
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,189,154David A Barbie · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation
$2,189,065Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2018 · AI
B Cells in Health and Disease
$2,188,962Ignacio E. Sanz · Emory University · P01 · FY2014 · AI
SPORE in Skin Cancer
$2,186,863Meenhard Herlyn · Wistar Institute · P50 · FY2007 · CA
HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines
$2,186,845Novartis Vaccines And Diagnostics, Inc. · N01 · FY2013 · AI
Washington University SPORE in Pancreatic Cancer
$2,186,724William G Hawkins · Washington University · P50 · FY2016 · CA
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D
$2,186,217David C Montefiori · Duke University · N01 · FY2012 · AI
NIAID Microbiome Program
$2,185,953Niki Moutsopoulos · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,185,917Dana-Farber Cancer Institute · P01 · FY2005 · CA
Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates
$2,185,568Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI
Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates
$2,185,567Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$2,185,305Brian Murphy · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Mayo Clinic SPORE in Pancreatic Cancer
$2,185,002Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2015 · CA
Duke SPORE in Brain Cancer
$2,185,000John H Sampson · Duke University · P50 · FY2015 · CA
Seattle Cancer Consortium Breast SPORE
$2,185,000Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA
Mayo Clinic SPORE in Ovarian Cancer
$2,185,000Lynn C. Hartmann · Mayo Clinic Rochester · P50 · FY2011 · CA
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
$2,185,000Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA